Deep Tech Startups

Cosyne develops precision medicine for underserved brain diseases, combining scientific and technical work to help patients with neurological conditions.

2 investors

Covaron Advanced Materials develops high-performance coatings for high-heat and high-abrasion applications, including thermal coatings rated to point-source temperatures up to 1600°C and single-part spray abrasion and corrosion coatings. It serves industrial, aerospace, transportation, and defense customers.

2 investors

CREAL develops a light field display technology that projects images with real 3D depth for augmented and virtual reality devices, addressing the visual conflicts of conventional AR displays that use a fixed focal distance. The technology targets AR/VR applications, including uses such as surgical AR navigation.

2 investors

Creative 3D Technologies develops modular, multi-method hardware systems and digital infrastructure for Single-Cell Manufacturing, supporting end-to-end industrial production.

2 investors

CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.

2 investors

Cristal Therapeutics develops a proprietary copper-free click chemistry platform, CliCr®, used to create bioconjugate products with higher stability and faster reaction rates. The company licenses its CliCr® technology to partners for diagnostic and therapeutic applications.

2 investors

Crosslake is a global advisory firm serving private equity investors and their portfolio companies, offering technology due diligence, digital transformation strategy, and technology value creation. It provides services including security and architecture assessments, interim executive leadership (CTOs, CISOs, CIOs), M&A integration/separation, and benchmarking via its proprietary TechIndicators platform.

2 investors

CyberSwarm designs intelligent systems inspired by natural intelligence, building AI that learns and adapts. The page provides only high-level messaging about its approach without specifying products or target customers.

2 investors

Cyberwrite offers an AI-powered platform that analyzes data to produce financial risk assessments for cyber insurance decisions. It serves the cyber insurance market with explainable, defensible risk intelligence.

2 investors

CybExer develops immersive testing and training environments for cybersecurity skill development and resilience building. The company provides scalable cyber ranges designed for organizations to conduct realistic and effective cybersecurity training.

2 investors

Cyclana Bio is a biotech company developing therapeutic programs focused on the extracellular matrix and tissue-level disease biology, with a flagship focus on women's health conditions such as endometriosis. Based at the Babraham Research Campus in Cambridge, UK, its work builds on academic research into how the non-cellular component of tissue drives health and disease.

2 investors

Cyclone Labs builds ultra-maneuverable autonomous underwater robotic systems capable of rapid three-dimensional movement for maritime operations. Its applications include underwater threat interception, reconnaissance and surveillance, underwater construction and maintenance, infrastructure inspection, and perimeter defense.

2 investors

Cytosolix uses its Tumor Activated Permeability (TAP) platform to redesign small molecule oncology drugs into weakly-acidic derivatives that exploit tumor acidity to selectively target and accumulate in solid tumors while sparing healthy tissue. Based on research from Yale University, its pipeline includes an androgen receptor inhibitor for early-stage prostate cancer and additional inhibitors for breast and other cancers.

2 investors

Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system. It serves cell biologists working in therapeutic areas such as vascular biology, stem cell differentiation, cardiovascular and neurological disease, and oncology.

2 investors

DRisQ develops Modelworks, a software tool that automatically verifies designs created in Simulink and Stateflow, helping design engineers detect errors early and produce more maintainable designs. It targets design engineers working on software development, aiming to reduce design errors and provide evidence of design correctness.

2 investors

DashamLabs develops silica aerogel flexible insulation sheets using process innovations aimed at making high-performance thermal insulation cost-efficient and scalable. Based in India, it targets industries including oil & gas, automotive, cold chain, aerospace & defence, and construction.

2 investors

Dawn Aerospace builds space transportation infrastructure including flight-proven green chemical satellite propulsion systems, in-space refueling capabilities, and a reusable spaceplane. The company serves satellite operators and space economy participants seeking reliable, sustainable access to orbit and in-space mobility.

2 investors

Daxo Robotics develops a highly dexterous, tendon-driven robotic hand with 120 tendens and high degrees of freedom, offered with a Python-first API, ROS wrapper, and simulation assets. The hardware is aimed at robotics developers and researchers, with a limited release planned for Fall 2026.

2 investors

DcubedD builds space technology products. The About page emphasizes the company's culture of ambitious thinking and rapid iteration but provides little concrete detail about specific products or customers.

2 investors

DeepDetection develops dual-energy photon counting X-ray detectors used to inspect food products and detect foreign objects and contaminants that conventional X-ray systems miss. Its technology targets food quality assurance and product safety applications.

2 investors

Deep Science Ventures is a venture creator that combines scientific knowledge with founder-scientists to build companies across energy, agriculture, pharmaceuticals, and computation. It focuses on high-impact ventures aimed at addressing challenges facing humanity and the planet.

2 investors

DeepMirror develops AI software for hit-to-candidate molecule design in drug discovery, enabling teams to generate novel chemical candidates and predict molecular properties using proprietary data while maintaining strict data privacy and IP security.

2 investors

Deepnight develops AI-powered night vision cameras that use edge AI processing to enable high-performance imaging in extremely low-light conditions, targeting defense, consumer electronics, drones, and autonomous vehicles. The company embeds machine learning models into digital image sensors to achieve night vision capabilities that match or exceed conventional analog systems.

2 investors

DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.

2 investors